Cost & Effectiveness: Healthcare Reform and its Implications for Pharma & Devices

03-Dec-2009


John Freedman, Principal at Freedman HealthCare served as an expert speaker as part of an FX Conference series on cost and effectiveness. His session provided an overview of health care reform by understanding Massachusetts reform as a likely model. Dr. Freedman outlined how such changes are likely to impact clinicians, as well as medical suppliers, and outlined key macro trends related to performance measurement, improvement, efficiency and cost containment. For transcripts of the webinar, click here.
Subscribe to our newsletter!
Boston Web Designer